Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentaxonemal central pair projection

CFAP69 HYDIN

3.57e-062402GO:1990718
GeneOntologyCellularComponentaxonemal central apparatus

CFAP69 HYDIN

5.33e-056402GO:1990716
HumanPhenoMolluscoid pseudotumors

COL5A1 ZNF469 AEBP1

1.07e-067173HP:0000993
HumanPhenoPiezogenic pedal papules

COL5A1 AEBP1

6.27e-054172HP:0025509
DomainC-type_lectin_CS

PLA2R1 CLEC17A

3.63e-0343392IPR018378
DomainUbiquitin-rel_dom

RGL1 PTPN4 SACS

6.63e-03184393IPR029071
Pubmed

VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.

VIPR2 FOXP3

1.29e-06240225305591
Pubmed

Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments.

HDAC6 FOXP3

3.87e-06340228416194
Pubmed

Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms.

HDAC6 FOXP3

7.73e-06440222715468
Pubmed

Population-based meta-analysis in Caucasians confirms association with COL5A1 and ZNF469 but not COL8A2 with central corneal thickness.

COL5A1 ZNF469

7.73e-06440222814818
Pubmed

Choroid plexuses carry nodal-like cilia that undergo axoneme regression from early adult stage.

HDAC6 HYDIN TP73

8.99e-063540337890489
Pubmed

Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases.

PPP1R15A HDAC6

1.29e-05540214670976
Pubmed

New loci associated with central cornea thickness include COL5A1, AKAP13 and AVGR8.

COL5A1 ZNF469

1.93e-05640220719862
Pubmed

Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells.

TNFRSF10B UBASH3B

2.70e-05740215388581
Pubmed

The plasticity of regulatory T cell function.

TNFRSF10B FOXP3

5.77e-051040222013112
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

PRUNE2 ZNF469 AEBP1 AP5B1 TP73

1.30e-0443040535044719
Pubmed

E3-independent monoubiquitination of ubiquitin-binding proteins.

HDAC6 UBASH3B

1.34e-041540217588522
Pubmed

The endoplasmic reticulum stress response in aging and age-related diseases.

TNFRSF10B PPP1R15A

1.34e-041540222934019
Pubmed

Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.

PPM1M TNS2 PTPN4 CAD DBN1

4.88e-0457340528330616
Pubmed

A transcript map of a 2-Mb BAC contig in the proximal portion of the mouse X chromosome and regional mapping of the scurfy mutation.

HDAC6 FOXP3

7.07e-043440210857745
Pubmed

Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes.

TNFRSF10B PPP1R15A

7.07e-043440218776938
Pubmed

Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus.

COL5A1 ZNF469

7.49e-043540223291589
Pubmed

CDK5RAP3, a UFL1 substrate adaptor, is crucial for liver development.

TNFRSF10B PPP1R15A

7.93e-043640230635284
Pubmed

Rint1 inactivation triggers genomic instability, ER stress and autophagy inhibition in the brain.

TNFRSF10B PPP1R15A

9.79e-044040226383973
Pubmed

FBXL13 directs the proteolysis of CEP192 to regulate centrosome homeostasis and cell migration.

RGL1 SACS

1.08e-034240229348145
CytobandXp11.23

HDAC6 FOXP3

3.14e-0395402Xp11.23
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

PPP1R15A HDAC6 SACS HYDIN

1.90e-04181294694
GeneFamilyC-type lectin domain family

PLA2R1 CLEC17A

2.57e-0347292494
ToppCellfacs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL5A1 RGL1 PLA2R1 AEBP1 CFAP69

6.52e-071854058433a337625ff8398520e223ef92bf9bb0beb14c
ToppCellfacs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL5A1 RGL1 PLA2R1 AEBP1 CFAP69

6.52e-07185405049d793d043d5d434f143025de49dd210d18756c
ToppCellfacs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL5A1 RGL1 PLA2R1 AEBP1 CFAP69

6.52e-0718540563200c42565eea596f9b00728e70e544b8d50a7f
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 COL5A1 AEBP1 SLC22A17 HYDIN

8.03e-07193405ffa1932da2979d7b63dbac32eb5788346a3f5b2a
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

GPRASP1 COL5A1 PTPN4 SACS

1.51e-0516740483969c36ac44b96afc9aa09400a99fa2b487f7ff
ToppCellfacs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AEBP1 ADAM28 HYDIN TP73

1.58e-0516940412bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 COL5A1 UBASH3B HYDIN

1.85e-05176404327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCellPericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id

PRUNE2 COL5A1 VIPR2 AEBP1

2.07e-05181404ff445a8e56522e57e27405184d123cf905caf8cc
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 COL5A1 UBASH3B HYDIN

2.07e-051814046956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCellHippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-C1ql1-Inhibitory_Neuron.Gad1Gad2_Pvalb.C1ql1_(Interneuron,_Chandelier)-|Hippocampus / BrainAtlas - Mouse McCarroll V32

VIPR2 ADAM28 AP5B1

2.37e-0562403852a5e778f212b63b9216cd7048972eb35f343c8
ToppCellHippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-C1ql1-Inhibitory_Neuron.Gad1Gad2_Pvalb.C1ql1_(Interneuron,_Chandelier)|Hippocampus / BrainAtlas - Mouse McCarroll V32

VIPR2 ADAM28 AP5B1

2.37e-056240313d05f73bc15fcfcf2aaa82b74b76753d4abc0ca
ToppCellHippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-C1ql1|Hippocampus / BrainAtlas - Mouse McCarroll V32

VIPR2 ADAM28 AP5B1

2.37e-05624037372aff17fc18bd4fee0655254796e60f6b25d24
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 COL5A1 UBASH3B HYDIN

2.45e-05189404904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell(1)_T_CD8_gd|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)

VIPR2 PTPN4 DBN1 OPHN1

2.45e-0518940462eda4bcfd21d5025ac676d524994ede22721c1d
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

COL5A1 RGL1 TNS2 AEBP1

2.45e-05189404c734e5693808a0333139e87bd5be2597a9252afe
ToppCellfacs-Lung-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CFAP69 ADAM28 HYDIN TP73

2.55e-051914046a8fc9dc1a4c7115862e8f20204fa2f95e50e22f
ToppCellfacs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

COL5A1 TNS2 DBN1 AEBP1

2.71e-051944047b6ec45adb7ece3c8a7b78c5782413b5825effe2
ToppCellLA-08._Macrophage|World / Chamber and Cluster_Paper

RGL1 UBASH3B RHBDF2 ADAM28

2.71e-05194404c1805572bcc11b1cd29083329d7b5911489fb758
ToppCellLA-08._Macrophage|LA / Chamber and Cluster_Paper

RGL1 UBASH3B RHBDF2 ADAM28

2.77e-051954045e1d5bdb8874091f5a2b1d0a8cc9008165718a97
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

VIPR2 PTPN4 DBN1 UBASH3B

2.77e-051954040a72b8446399807ace5b6c72f865bb40dbd9e92d
ToppCell3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Trm_Tgd|GI_small-bowel / Manually curated celltypes from each tissue

PTPN4 DBN1 UBASH3B ADAM28

2.82e-0519640484cab9390794fe50203834b745722bf11c208ebd
ToppCellCOVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations)

COL5A1 PLA2R1 AEBP1 CFAP69

2.88e-05197404f1c8936986123a3151140c374fcd62d6705c530b
ToppCell3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL5A1 VIPR2 TNS2 ADAM28

2.88e-05197404ad6c200a193a15360d17463e18a465ce1b90b8da
ToppCellTCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma|TCGA-Bladder / Sample_Type by Project: Shred V9

COL5A1 RHBDF2 AEBP1 FOXP3

2.94e-0519840465875fbd99393cdd62595c713ab90db06d28081f
ToppCell3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL5A1 VIPR2 AEBP1 ADAM28

3.00e-0519940430ab0750d51f168b18c434c974d24a4e70f29cc7
ToppCell3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL5A1 TNS2 AEBP1 ADAM28

3.00e-05199404a272c54baf8de59c0f259e6498d144a0de8d8924
ToppCell3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL5A1 VIPR2 TNS2 ADAM28

3.00e-05199404a697b3f0760e66bad8ea8d83cf6fea5934692c56
ToppCell3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL5A1 VIPR2 AEBP1 ADAM28

3.00e-0519940436883044787a9fb79cf7e83a7da8e34eea83f2f1
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PRUNE2 COL5A1 RGL1 AEBP1

3.05e-05200404a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL5A1 TNS2 AEBP1 ADAM28

3.05e-05200404d87ca8b0007b1743ae23ebd3c7e8aa7f53e39335
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

COL5A1 TNS2 FOXP3

1.96e-04126403feedea978d76de326c14da5149e57d0d767271b9
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

COL5A1 TNS2 FOXP3

1.96e-041264036311cc64320db7e24a09065ebdf054f5f551b182
ToppCellAdult-Mesenchymal-chondrocyte-D122|Adult / Lineage, Cell type, age group and donor

COL5A1 TNS2 SLC22A17

3.15e-0414840381a1e6fdd942a612bf523c59b8b4974f6ca1fdce
ToppCellE18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PRUNE2 HFE FOXP3

3.54e-0415440379ebda35dd1719e157738d7c13e5b8ccc3991f03
ToppCell10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue

PRUNE2 HFE RGL1

3.68e-041564039a897fc79c4fae94c5f2e9012d65297f9225e5e3
ToppCellsevere_influenza-NK_CD56bright|severe_influenza / disease group, cell group and cell class (v2)

VIPR2 PTPN4 AEBP1

3.75e-04157403fabaf54429dd5a899f9192f0d42522109ca36b9b
ToppCellCOPD-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class

COL5A1 DBN1 SACS

3.82e-041584038f66979e92f886d86cecbd26aaa0c5915c049734
ToppCellAdult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor

GPRASP1 UBASH3B AEBP1

3.82e-04158403410fa08c9d880d27e80ec939fa5ba5a41dcb31ab
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZNF469 CLEC17A ADAM28

3.82e-0415840341cf950983f47a9e55d56041b301006b42853b37
ToppCellAdult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor

COL5A1 TNS2 AEBP1

3.89e-041594033f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCellPND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PPM1M HFE UBASH3B

4.03e-04161403afc719ffa53ab34c5628da47936da1f731dceab1
ToppCellPND03-Immune-Immune_Myeloid-DC-cDC1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HFE PHKA2 UBASH3B

4.03e-041614030e2b54a63781397f6b99eb0e201fbb820cbd7cc6
ToppCellAdult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor

PRUNE2 VIPR2 SACS

4.03e-0416140364891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCelllymphoid-B_cell-pro-B|World / Lineage, cell class and subclass

COL5A1 DBN1 AEBP1

4.03e-0416140323138e579f07d5a6f20d41457cb573b4ac95a4ef
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

PPP1R15A RHBDF2 ADAM28

4.18e-041634036bed27d2f67a430a847da5eb47878d14b4949c45
ToppCellPND14-Immune-Immune_Myeloid-DC-cDC1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PPM1M HFE UBASH3B

4.25e-0416440390404b3b6b6a9b88a75cba09baa94c718e577c44
ToppCelldroplet-Lung-nan-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPM1M HFE DBN1

4.25e-04164403a67dd181eba275c191f4d0cab13df30eaa3ad913
ToppCellBAL-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters

PPM1M DBN1 SLC22A17

4.25e-041644034bd9629d054545d1e3f9e5c127b5ac2388637106
ToppCell10x5'-Lung-Lymphocytic_B-Naive_B_cells|Lung / Manually curated celltypes from each tissue

AEBP1 CLEC17A ADAM28

4.33e-041654031776e7db80d7cf6b449fa8635a111705a59231b4
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9

PAN2 PTPN4 CFAP69

4.41e-0416640332d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCelldroplet-Marrow-nan-24m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRUNE2 HFE RGL1

4.41e-04166403b3d9b61847c6c96b8cb28b8a6aeda52f43c706ab
ToppCelldroplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPM1M HFE DBN1

4.49e-04167403f33cef917fa733adf6d5a9a9e989a4d9fd462a8f
ToppCellTCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9

COL5A1 ZNF469 FOXP3

4.56e-04168403aefea14b8b1c1b6a05f827effd22ba15274fddc9
ToppCellmild_COVID-19-HSPC|mild_COVID-19 / disease group, cell group and cell class (v2)

ZNF772 AEBP1 CFAP69

4.56e-0416840390b33962adb77d8326dee403712118398b4d1315
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass

HFE OPHN1 TP73

4.64e-04169403625788d86f0ceebcf2653a251db1f1a9f9746d29
ToppCell5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP69 HYDIN TP73

4.64e-041694038bca402e144819cb9a8d431d6bf9429be2fff6d6
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

VIPR2 TNS2 AEBP1

4.64e-041694036ff1172da690ca17f7108f1617b255b766971a57
ToppCell5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL5A1 TNS2 ADAM28

4.64e-04169403c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL5A1 ZNF469 AEBP1

4.64e-04169403031465190cd3623a25ef2b868daab8d932c8ff08
ToppCellNS-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CFAP69 IQCC TP73

4.72e-04170403f6a0162bb690dbc19ff1cec64cb933744ad3b496
ToppCell5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIPR2 PPP1R15A ADAM28

4.72e-04170403a7184dc41f90caa753860ed0f65a18133f84bc5f
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

COL5A1 UBASH3B AEBP1

4.72e-0417040314aa86a4f526ed6986afcb28c49225522055550c
ToppCellmild_COVID-19-HSPC|World / disease group, cell group and cell class (v2)

ZNF772 AEBP1 CFAP69

4.72e-0417040385c476e0bc496445e868a88849960598d97bdea2
ToppCelldroplet-Spleen-nan-18m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HFE RGL1 DBN1

4.81e-041714034a2e6ea9674bf23e8012ef0bb2bf19ce1f55fcd5
ToppCelldroplet-Lung-nan-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPM1M HFE DBN1

4.81e-0417140306fe7eeffc6e0735342b88e1d1ae26a9b477fece
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL5A1 ZNF469 AEBP1

4.81e-0417140315cb4670ff4234ac46aea8a5911138d6913c4482
ToppCelldroplet-Spleen-nan-24m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRUNE2 HFE RGL1

4.81e-0417140335acc5c3e36bc605603c0d45375f2cf3c3e9d4cd
ToppCellHealthy/Control-MAIT|World / Disease group and Cell class

GPRASP1 DBN1 CFAP69

4.81e-0417140361515114b17816a8f9ef6a57262eb9e977b6ede4
ToppCellfacs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGL1 HDAC6 AP5B1

4.89e-041724037fb31ccbcd0204c3612986a6bc20d57ed6825e9c
ToppCellCOVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type

PRUNE2 AEBP1 SACS

4.89e-0417240336a96714a0eb6ac438648135336c9791881ddadb
ToppCelldroplet-Spleen-nan-18m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HFE RGL1 DBN1

4.89e-04172403850e4c9e9003807c19695be4b13121b0808a9389
ToppCelldroplet-Spleen-nan-18m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HFE RGL1 DBN1

4.89e-04172403018d8160cfcb7882475620dc678f48a69a0f643e
ToppCellNS-critical-d_0-4-Epithelial-FOXN4+|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PLA2R1 HDAC6 TP73

4.89e-04172403a00bb44d33658cb3a98accd6b60f3ce964c425b4
ToppCellfacs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGL1 HDAC6 AP5B1

4.89e-041724032a4614b3d25e8c6b095e6992d8ca35371dcdb5e1
ToppCell10x5'-Lung-Lymphocytic_B-Memory_B_cells|Lung / Manually curated celltypes from each tissue

AEBP1 CLEC17A ADAM28

4.89e-041724032cb2dc7cfd6db5a98a393b1a84c23abf3d692a53
ToppCellPND07-28-samps-Myeloid-Macrophage-CD163+_Macrophage|PND07-28-samps / Age Group, Lineage, Cell class and subclass

PRUNE2 HFE OPHN1

4.89e-041724039a659442dc41bd2a4361a7e38a7ee37a39781667
ToppCellCOVID-19_Mild-PLT_2|COVID-19_Mild / Disease Group and Platelet Clusters

GPRASP1 ZC3HC1 TP73

4.97e-04173403d11705e56b6b21eec963ea224717f27680c781ed
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

PPP1R15A RHBDF2 ADAM28

4.97e-04173403d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCellAdult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor

PRUNE2 VIPR2 SACS

4.97e-04173403a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc
ToppCellHealthy/Control-MAIT|Healthy/Control / Disease group and Cell class

DBN1 PPP1R15A CFAP69

4.97e-0417340356247c1e07477a8922fe2e3950ae05e2217fd77c
ToppCellfacs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AEBP1 HYDIN TP73

4.97e-0417340366f37c1437705734b20601656fa4aa1d92ca30be
ToppCellfacs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AEBP1 HYDIN TP73

4.97e-04173403649b08a409095592cccf31883be69c754411280d
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RHBDF2 CLEC17A ADAM28

5.06e-041744031b2a2129c08bac01fc638692313b196759a1e0d7
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RHBDF2 CLEC17A ADAM28

5.06e-041744035bde24eb588dc588efc413811379548120ec0c7f
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TNS2 HDAC6 SACS

5.14e-041754038b498eea1ec1c1f27b171025c3d08adf3687bafc
ToppCellTCGA-Thymus-Primary_Tumor-Thymoma-Type_AB|TCGA-Thymus / Sample_Type by Project: Shred V9

PRUNE2 TNS2 PLA2R1

5.14e-0417540350f9b994bdd389158f92f891944ea81b2fb15eef
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TNS2 HDAC6 SACS

5.14e-04175403a5db428b078938627e61b7e944c1e0c1d61ac2da
ToppCellfacs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFAP69 HYDIN TP73

5.23e-04176403ed788a5969edfd1199828ca5b0dd34e7f29c4d30
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RHBDF2 CLEC17A ADAM28

5.23e-04176403d0a3e176df1270968efa79c00dc941c5e1c4f7aa
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

RHBDF2 CLEC17A ADAM28

5.23e-04176403274458d80f9f3f080248cbf64e4784ef351e7254
ToppCelldroplet-Fat-SCAT-30m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PTPN4 MTURN IQCC

5.31e-04177403baf78a8dad55f124f56585f88b10b58c0269680f
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

RHBDF2 CLEC17A ADAM28

5.31e-04177403b07e6139618d888a9fd7cf43cad0d86a3f63e09e
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

RHBDF2 CLEC17A ADAM28

5.31e-041774036376ec12322c04d5d37ec2fdc376700464cbc7fb
ToppCellfacs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPM1M DBN1 UBASH3B

5.31e-041774033cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

COL5A1 HYDIN OPHN1

5.40e-04178403c20f050344a2e120e685e2a7fe36c6dfc1dc37b6
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9

COL5A1 ZNF469 AEBP1

5.40e-04178403142879e9393e721f9b05a6bb46995c9d6d713c95
ToppCellfacs-Marrow-KLS-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPM1M HFE DBN1

5.40e-041784036bad4439a1692332f70135ff446a1048fa4c399d
ToppCellPBMC-Severe-cDC_11|Severe / Compartment, Disease Groups and Clusters

PPM1M PLA2R1 DBN1

5.40e-041784030667abc05eb2254710b9c648c65b7cfdfe7831b7
ToppCellfacs-Marrow-KLS-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPM1M HFE DBN1

5.40e-041784033f6feb4ed7779cf5684f52939350b41d7718c3c6
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRUNE2 RGL1 OPHN1

5.49e-041794036eb84fe9691ad40127b2d1f1c672428333c8fab4
DrugErythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A

PHKA2 COL5A1 TNS2 TNFRSF10B FBXO9 SLC22A17

1.10e-061954065329_DN
DrugTimolol maleate salt [26921-17-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A

HFE COL5A1 RGL1 PPP1R15A CFAP69 SLC22A17

1.13e-061964065280_DN
DrugZidovudine, AZT [30516-87-1]; Down 200; 15uM; MCF7; HT_HG-U133A

POMT2 HFE VIPR2 TNS2 CFAP69 SLC22A17

1.17e-061974063211_DN
DrugHecogenin [467-55-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A

POMT2 HFE COL5A1 TNFRSF10B HDAC6 IQCC

1.17e-061974063457_UP
Drugtrifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA

HFE GPRASP1 VIPR2 TNFRSF10B PPP1R15A

1.23e-05172405910_UP
DrugThioguanosine [85-31-4]; Up 200; 12.6uM; MCF7; HT_HG-U133A

POMT2 GPRASP1 COL5A1 TNFRSF10B PPP1R15A

1.99e-051904052619_UP
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A

HFE PHKA2 COL5A1 PPP1R15A ADAM28

2.04e-051914055953_UP
DrugAld1.1-H_000455; Up 200; 10uM; MCF7; HT_HG-U133A

HFE PHKA2 COL5A1 TNFRSF10B ADAM28

2.04e-051914057542_UP
Drug(d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A

POMT2 PRUNE2 HFE FBXO9 CFAP69

2.15e-051934054138_DN
DrugFendiline hydrochloride [13636-18-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A

HFE PHKA2 TNS2 HDAC6 SACS

2.26e-051954057188_DN
DrugNafcillin sodium salt monohydrate [7177-50-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A

POMT2 HFE TNS2 DBN1 SLC22A17

2.26e-051954054103_DN
DrugBrinzolamide [138890-62-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A

POMT2 HFE VIPR2 TNFRSF10B CFAP69

2.37e-051974053230_DN
DrugVigabatrin [60643-86-9]; Down 200; 31uM; MCF7; HT_HG-U133A

HFE TNS2 TNFRSF10B DBN1 RHBDF2

2.37e-051974055415_DN
DrugHarmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A

POMT2 COL5A1 RGL1 RHBDF2 CFAP69

2.37e-051974054968_UP
DrugLY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A

HFE GPRASP1 VIPR2 TNS2 IQCC

2.43e-051984056976_UP
DrugTolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; MCF7; HT_HG-U133A

POMT2 HFE TNFRSF10B CFAP69 FOXP3

2.43e-051984054844_UP
DrugAzacyclonol [115-46-8]; Up 200; 15uM; HL60; HG-U133A

POMT2 HFE VIPR2 IQCC FOXP3

2.43e-051984052020_UP
DrugTodralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; PC3; HT_HG-U133A

POMT2 PAN2 VIPR2 TNS2 HDAC6

2.43e-051984051799_UP
DrugHexetidine [141-94-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A

HFE GPRASP1 COL5A1 DBN1 RHBDF2

2.43e-051984055420_DN
DrugAcetazolamide [59-66-5]; Up 200; 18uM; PC3; HT_HG-U133A

POMT2 COL5A1 VIPR2 TNS2 MCM9

2.49e-051994051808_UP
DrugEthionamide [536-33-4]; Down 200; 24uM; PC3; HT_HG-U133A

POMT2 COL5A1 VIPR2 PPP1R15A SLC22A17

2.49e-051994054593_DN
DrugTerbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A

PRUNE2 HFE VIPR2 DBN1 HDAC6

2.49e-051994056240_UP
DrugIsopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A

POMT2 HFE COL5A1 TNS2 FBXO9

2.49e-051994056097_DN
DrugA 192621

TNFRSF10B PPP1R15A

1.08e-049402ctd:C120508
Drugresveratrol; Up 200; 10uM; MCF7; HT_HG-U133A_EA

POMT2 TNFRSF10B PPP1R15A RHBDF2

2.76e-04180404958_UP
DrugPrimaquine diphosphate [63-45-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A

POMT2 VIPR2 PPP1R15A SLC22A17

2.76e-041804043279_UP
DrugBetulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A

POMT2 HFE PPP1R15A RHBDF2

3.26e-041884043281_UP
DrugLorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A

POMT2 HFE TNFRSF10B DBN1

3.33e-041894045254_DN
DrugSecurinine [5610-40-2]; Down 200; 18.4uM; PC3; HT_HG-U133A

POMT2 TNS2 FBXO9 CFAP69

3.39e-041904044493_DN
DrugTiclopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; MCF7; HT_HG-U133A

HFE TNFRSF10B PPP1R15A HDAC6

3.39e-041904044155_UP
DrugMepenzolate bromide [76-90-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A

HFE PHKA2 GPRASP1 HDAC6

3.46e-041914046024_DN
DrugHarpagoside [19210-12-9]; Down 200; 8uM; MCF7; HT_HG-U133A

HFE VIPR2 FBXO9 PPP1R15A

3.46e-041914044981_DN
DrugClioquinol [130-26-7]; Up 200; 13uM; MCF7; HT_HG-U133A

POMT2 PRUNE2 HFE CFAP69

3.46e-041914046461_UP
Drugestradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A

HFE PHKA2 RGL1 SLC22A17

3.53e-041924045238_UP
DrugMetixene hydrochloride [1553-34-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A

HFE COL5A1 TNS2 SLC22A17

3.53e-041924043313_UP
DrugDihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A

POMT2 HFE DBN1 PPP1R15A

3.53e-041924044152_DN
Drugtroglitazone; Up 200; 10uM; MCF7; HT_HG-U133A

TNS2 TNFRSF10B HDAC6 SLC22A17

3.60e-041934041657_UP
DrugMetoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; MCF7; HT_HG-U133A

VIPR2 TNS2 IQCC FOXP3

3.60e-041934046846_UP
DrugTetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A

COL5A1 VIPR2 TNS2 DBN1

3.60e-041934042748_UP
Drug5152487; Up 200; 10uM; MCF7; HT_HG-U133A_EA

HFE COL5A1 TNS2 FOXP3

3.60e-04193404896_UP
DrugRapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A

PRUNE2 HFE TNS2 DBN1

3.67e-041944047001_UP
DrugPhenacetin [62-44-2]; Down 200; 22.4uM; MCF7; HT_HG-U133A

HFE TNS2 TNFRSF10B CFAP69

3.67e-041944044111_DN
DrugRapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A

HFE FBXO9 PPP1R15A HDAC6

3.67e-041944041632_UP
DrugDibucaine [85-79-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A

POMT2 GPRASP1 COL5A1 SLC22A17

3.67e-041944044149_DN
DrugRiluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A

HFE PHKA2 COL5A1 PPP1R15A

3.67e-041944042295_DN
DrugIndoprofen [31842-01-0]; Up 200; 14.2uM; MCF7; HT_HG-U133A

POMT2 HFE GPRASP1 IQCC

3.67e-041944043345_UP
DrugPropantheline bromide [50-34-0]; Up 200; 9uM; MCF7; HT_HG-U133A

POMT2 HFE DBN1 PPP1R15A

3.67e-041944044798_UP
DrugGlimepiride [93479-97-1]; Up 200; 8.2uM; PC3; HT_HG-U133A

POMT2 HFE COL5A1 ADAM28

3.67e-041944046628_UP
DrugSpiramycin [8025-81-8]; Up 200; 4.8uM; MCF7; HT_HG-U133A

PRUNE2 AEBP1 CFAP69 IQCC

3.67e-041944043938_UP
DrugNaproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A

HFE VIPR2 TNS2 SLC22A17

3.67e-041944045457_DN
DrugAcetohexamide [968-81-0]; Up 200; 12.4uM; HL60; HT_HG-U133A

HFE PHKA2 VIPR2 PTPN4

3.75e-041954041870_UP
Drug(R)-Propranolol hydrochloride [13071-11-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A

HFE TNS2 FBXO9 PPP1R15A

3.75e-041954043553_UP
DrugLY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A

POMT2 HFE TNS2 TNFRSF10B

3.75e-041954045213_DN
DrugChlorogenic acid [327-97-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A

HFE COL5A1 VIPR2 IQCC

3.75e-041954043282_UP
DrugButoconazole nitrate [32872-77-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A

HFE COL5A1 DBN1 FBXO9

3.75e-041954045388_DN
DrugFamprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A

PRUNE2 RGL1 SLC22A17 ADAM28

3.75e-041954043834_UP
Drugtroglitazone; Down 200; 10uM; MCF7; HT_HG-U133A

POMT2 HFE GPRASP1 VIPR2

3.75e-041954045229_DN
DrugGabapentin [60142-96-3]; Up 200; 23.4uM; MCF7; HT_HG-U133A

HFE PHKA2 COL5A1 IQCC

3.75e-041954043472_UP
DrugCapsaicin [404-86-4]; Up 200; 13uM; MCF7; HT_HG-U133A

PRUNE2 HFE AEBP1 CFAP69

3.75e-041954045673_UP
DrugHecogenin [467-55-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A

POMT2 HFE TNFRSF10B DBN1

3.75e-041954047175_UP
DrugNiridazole [61-57-4]; Down 200; 18.6uM; HL60; HT_HG-U133A

HFE TNFRSF10B PPP1R15A RHBDF2

3.82e-041964042440_DN
DrugIsosorbide dinitrate [87-33-2]; Down 200; 17uM; HL60; HT_HG-U133A

GPRASP1 VIPR2 DBN1 RHBDF2

3.82e-041964042183_DN
DrugSimvastatin [79902-63-9]; Down 200; 9.6uM; HL60; HT_HG-U133A

PRUNE2 PPP1R15A CFAP69 ADAM28

3.82e-041964043002_DN
DrugNaloxone hydrochloride [357-08-4]; Up 200; 11uM; MCF7; HT_HG-U133A

POMT2 HFE CFAP69 FOXP3

3.82e-041964045606_UP
DrugLasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A

POMT2 HFE RGL1 TNS2

3.82e-041964043360_UP
Drughaloperidol; Down 200; 10uM; MCF7; HT_HG-U133A

HFE COL5A1 IQCC ADAM28

3.82e-041964045604_DN
Drug2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A

POMT2 GPRASP1 TNS2 SLC22A17

3.82e-041964041181_UP
DrugPempidine tartrate [546-48-5]; Up 200; 13uM; PC3; HT_HG-U133A

HFE HDAC6 CFAP69 IQCC

3.82e-041964044307_UP
DrugGraveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A

COL5A1 VIPR2 CFAP69 IQCC

3.82e-041964044276_DN
DrugRonidazole [7681-76-7]; Up 200; 20uM; PC3; HT_HG-U133A

PHKA2 GPRASP1 COL5A1 MCM9

3.82e-041964047131_UP
DrugAspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; MCF7; HT_HG-U133A

HFE TNS2 PPP1R15A SLC22A17

3.82e-041964044125_DN
DrugLobeline alpha (-) hydrochoride [134-63-4]; Up 200; 10.6uM; HL60; HG-U133A

POMT2 HFE VIPR2 IQCC

3.82e-041964041770_UP
DrugEpicatechin-(-) [154-23-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A

HFE VIPR2 RGL1 IQCC

3.82e-041964044419_DN
DrugPentetic acid [67-43-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A

POMT2 HFE COL5A1 RGL1

3.82e-041964045629_UP
DrugF0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A

PRUNE2 TNS2 PLA2R1 CFAP69

3.82e-041964046396_DN
Drugwortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A

HFE TNS2 FBXO9 SLC22A17

3.82e-041964045240_DN
DrugDoxepin hydrochloride [1229-29-4]; Up 200; 12.6uM; PC3; HT_HG-U133A

PRUNE2 HFE GPRASP1 IQCC

3.89e-041974046337_UP
DrugNizatidine [76963-41-2]; Down 200; 12uM; MCF7; HT_HG-U133A

HFE COL5A1 PPP1R15A AEBP1

3.89e-041974045406_DN
DrugIsopropamide iodide [71-81-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A

POMT2 HFE COL5A1 TNS2

3.89e-041974046781_DN
DrugAsiaticoside [16830-15-2]; Up 200; 4.2uM; MCF7; HT_HG-U133A

HFE TNS2 HDAC6 TP73

3.89e-041974043504_UP
DrugMethoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; MCF7; HT_HG-U133A

POMT2 HFE VIPR2 PPP1R15A

3.89e-041974042848_DN
DrugHydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A

HFE COL5A1 VIPR2 SLC22A17

3.89e-041974046011_DN
DrugMethylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; HL60; HT_HG-U133A

HDAC6 RHBDF2 CFAP69 ADAM28

3.89e-041974042994_DN
DrugSuprofen [40828-46-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A

POMT2 TNS2 TNFRSF10B CFAP69

3.89e-041974044123_DN
DrugQuinic acid [86-68-0]; Up 200; 19.6uM; MCF7; HT_HG-U133A

TNS2 PPP1R15A HDAC6 FOXP3

3.89e-041974043540_UP
DrugNadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A

HFE COL5A1 VIPR2 IQCC

3.89e-041974046091_DN
DrugSertaconazole nitrate [99592-39-9]; Up 200; 8uM; MCF7; HT_HG-U133A

DBN1 IQCC ADAM28 FOXP3

3.89e-041974046811_UP
DrugKetorolac tromethamine [74103-07-4]; Up 200; 10.6uM; PC3; HT_HG-U133A

POMT2 COL5A1 VIPR2 TNFRSF10B

3.89e-041974047286_UP
DrugHaloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A

POMT2 COL5A1 CFAP69 ADAM28

3.89e-041974045638_UP
DrugClofilium tosylate [92953-10-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A

HFE TNS2 AEBP1 ADAM28

3.89e-041974046830_UP
DrugNalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A

HFE TNFRSF10B CFAP69 IQCC

3.89e-041974047177_UP
DrugGriseofulvin [126-07-8]; Up 200; 11.2uM; PC3; HT_HG-U133A

POMT2 HFE COL5A1 HDAC6

3.89e-041974043664_UP
DrugChlorthalidone [77-36-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A

HFE COL5A1 RHBDF2 SLC22A17

3.89e-041974046800_DN
DrugAmyleine hydrochloride [532-59-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A

HFE COL5A1 TNFRSF10B IQCC

3.89e-041974041491_UP
DrugPicotamide monohydrate [80530-63-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A

POMT2 GPRASP1 COL5A1 FBXO9

3.89e-041974046787_DN
DrugLY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A

HFE PHKA2 GPRASP1 VIPR2

3.89e-041974041641_UP
DrugTodralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; MCF7; HT_HG-U133A

HFE PHKA2 VIPR2 TNFRSF10B

3.89e-041974041677_UP
DrugCefuroxime sodium salt [56238-63-2]; Up 200; 9uM; MCF7; HT_HG-U133A

HFE COL5A1 VIPR2 CFAP69

3.89e-041974046261_UP
DrugPentamidine isethionate [140-64-7]; Down 200; 6.8uM; PC3; HT_HG-U133A

PHKA2 VIPR2 TNFRSF10B CFAP69

3.89e-041974044573_DN
DrugParomomycin sulfate [1263-89-4]; Down 200; 5.6uM; MCF7; HT_HG-U133A

HFE VIPR2 TNFRSF10B PPP1R15A

3.97e-041984043356_DN
Diseaseglycoprotein measurement

TNFRSF10B UBASH3B HYDIN

4.50e-04119373EFO_0004555
Diseasecolorectal cancer (is_implicated_in)

HFE TP73 FOXP3

4.72e-04121373DOID:9256 (is_implicated_in)
Diseaseeye measurement

COL5A1 ZNF469

5.26e-0427372EFO_0004731
DiseaseAdult T-Cell Lymphoma/Leukemia

TP73 FOXP3

6.95e-0431372C0023493
Diseasebreast cancer (is_implicated_in)

HFE ADAM28 TP73

8.81e-04150373DOID:1612 (is_implicated_in)
Diseasecervix uteri carcinoma in situ (is_marker_for)

HDAC6 TP73

1.28e-0342372DOID:8991 (is_marker_for)
Diseasehepatocellular carcinoma (implicated_via_orthology)

CAD MCM9

1.73e-0349372DOID:684 (implicated_via_orthology)
Diseasereticulocyte measurement

HFE RGL1 ZNF469 PPP1R15A UBASH3B SLC22A17

1.84e-031053376EFO_0010700

Protein segments in the cluster

PeptideGeneStartEntry
PEDPSFWDCFCFTEE

AASDHPPT

286

Q9NRN7
WIPPDCDDSSVVFHF

ADAM28

651

Q9UKQ2
GCDKFPHESELPREW

AEBP1

876

Q8IUX7
WLDQCAEDFREPPHF

RGL1

151

Q9NZL6
HFPCEESEGEATWEE

IQCC

86

Q4KMZ1
DPKCPGDVDFHNSDW

OPHN1

426

O60890
IAWPDHGVPDDSSDF

PTPN4

816

P29074
EGCVHLWTDSPEPSF

PAN2

351

Q504Q3
WPGCEKVFEEPEDFL

FOXP3

201

Q9BZS1
GDNFHVWSESEDCLP

MTURN

51

Q8N3F0
FFEELWDSCLPEGAE

AP5B1

781

Q2VPB7
TCWDADPVPEEEEGF

DBN1

631

Q16643
DGQDHLEFCPDTLDW

HFE

141

Q30201
PDEWADFGFDLPDCK

TP73

606

O15350
LHPIFEGEHWEGPEF

HYDIN

4661

Q4G0P3
WVFPPQAEAEEDCHS

FBXO9

6

Q9UK97
CPADPDWIAFIHSND

DPP8

221

Q6V1X1
DLQLCHPDFPDGEYW

COL5A1

1641

P20908
EFHCLWDDSFPEGPE

HDAC6

96

Q9UBN7
LEWCESEDPFFSHGN

CFAP69

451

A5D8W1
WPDPDLVHDDFSVIC

SACS

1946

Q9NZJ4
SDFQWPRDDHGDVDC

PHKA2

746

P46019
AEDWGEAEPCPFRVA

PPP1R15A

496

O75807
FTLPELGDEAFDCDW

MCM9

1121

Q9NXL9
FWAGDEAHFESNPSP

GPRASP1

1006

Q5JY77
PFPAWSAFGKEDHDE

PRUNE2

796

Q8WUY3
LDEPPHICWDETHFG

POMT2

76

Q9UKY4
GFAPPDFNHCLKDWD

SLC22A17

61

Q8WUG5
WSPEVNFEPFVEDHC

PLA2R1

316

Q13018
FWEPEEPNNIHDEDC

CLEC17A

336

Q6ZS10
AHEKFCFWPDSPSPD

ZC3HC1

151

Q86WB0
FGAEEEWLTLCPEEF

PPM1M

101

Q96MI6
CFDDFADLVPFDSWE

TNFRSF10B

341

O14763
AVDWHFEEAVDGECP

CAD

1361

P27708
DGWSETFPDFVDACG

VIPR2

96

P41587
CLCHEDPWEDEDPAG

ZNF469

2891

Q96JG9
DWLFSHVGDPFLDDP

UBASH3B

71

Q8TF42
CEEPASSGAHIWPDD

RHBDF2

556

Q6PJF5
DPGCWHGMEDEEIPF

ZNF772

106

Q68DY9
PWENVCHLFAELDPD

TNS2

1376

Q63HR2